US OptionsDetailed Quotes
LLY240705C570000
- 339.74
- 0.000.00%
15min DelayTrading Jun 28 15:51 ET
0.00High0.00Low
0.00Open339.74Pre Close0 Volume9 Open Interest570.00Strike Price0.00Turnover0.00%IV-0.35%PremiumJul 5, 2024Expiry Date342.92Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.66Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
Sign in to post a comment
The first half of 2024 has been a consistently profitable period for my investments, largely driven by my disciplined and strategic responses to earnings reports and news ![]()
. And by carefully analyzing financial statements and market sentiment, I have been able to profit significantly from selling options and employing strangle strategies. Additionally, buying stocks ahead of anticipated positive news and earnings reports has proven to be highly effective! ...
+4
91
27
$Eli Lilly and Co(LLY.US$ next month USD 1000
1
We used to have FAANG ... currently we have the magnificent 7 ... may I introduce you to what's next (Thoughts?)
MEATMAAN
Microsoft $Microsoft(MSFT.US$
Eli Lilly $Eli Lilly and Co(LLY.US$
Apple $Apple(AAPL.US$
Tesla $Tesla(TSLA.US$
Meta $Meta Platforms(META.US$
Amazon $Amazon(AMZN.US$
Alphabet $Alphabet-A(GOOGL.US$
Nvidia $NVIDIA(NVDA.US$
MEATMAAN
Microsoft $Microsoft(MSFT.US$
Eli Lilly $Eli Lilly and Co(LLY.US$
Apple $Apple(AAPL.US$
Tesla $Tesla(TSLA.US$
Meta $Meta Platforms(META.US$
Amazon $Amazon(AMZN.US$
Alphabet $Alphabet-A(GOOGL.US$
Nvidia $NVIDIA(NVDA.US$
10
1
This is a very informative article. However, they made Eli Lilly's higher P/E ratio sound like a good thing. As a value investor, I would have to say that Novo Nordisk has a lot more room to climb. Eli Lilly stock could potentially undergo a longterm correction if the perceived value of their stock were to come down to a more realistic level. Unless of course if their earnings continue to compound as much as this last quarter.
4
$Microsoft(MSFT.US$ $Eli Lilly and Co(LLY.US$
👉 Key Highlights:
📍 Eli Lilly partners with OpenAI to leverage generative AI for new antimicrobials.
📍 Focus on treating drug-resistant pathogens through innovative AI technology.
📍 AMR is a major global health threat, exacerbated by misuse and overuse of antimicrobials.
📍 Partnership underscores Lilly's commitment to addressing significant health challenges.
📍 Collaboration aims to accelerate...
👉 Key Highlights:
📍 Eli Lilly partners with OpenAI to leverage generative AI for new antimicrobials.
📍 Focus on treating drug-resistant pathogens through innovative AI technology.
📍 AMR is a major global health threat, exacerbated by misuse and overuse of antimicrobials.
📍 Partnership underscores Lilly's commitment to addressing significant health challenges.
📍 Collaboration aims to accelerate...
3
No comment yet
Art of Trading RA : Very good, well done
, lots to understand from your trades.
约翰の理财库OP Art of Trading RA: Thank you
I love birds 约翰の理财库OP: hello bro , do you think this is a good idea ?
I love birds : btw congratulations for your 88k profit
约翰の理财库OP I love birds: Money market offer a safe and stable investment option for money you may need to access in the short term(not for long term) but liquidable T+0 day
View more comments...